| | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2024 ( Subtotal = $0 ) |
| 2024 | 2023 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111 | PHILADELPHIA | USA | Blood Diseases and Resources Research | 000 | 4 | 6/13/2024 | NON-COMPETING CONTINUATION | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $467,500 ) |
| 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111 | PHILADELPHIA | USA | Blood Diseases and Resources Research | 000 | 4 | 1/26/2023 | NON-COMPETING CONTINUATION | $467,500 |
|
| Issue Date FY: 2022 ( Subtotal = $454,090 ) |
| 2022 | 2022 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111 | PHILADELPHIA | USA | Blood Diseases and Resources Research | 000 | 3 | 2/25/2022 | NON-COMPETING CONTINUATION | $408,681 |
| 2022 | 2022 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111 | PHILADELPHIA | USA | Blood Diseases and Resources Research | 001 | 3 | 6/15/2022 | NON-COMPETING CONTINUATION | $45,409 |
|
| Issue Date FY: 2021 ( Subtotal = $467,500 ) |
| 2021 | 2021 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111 | PHILADELPHIA | USA | Blood Diseases and Resources Research | 000 | 2 | 3/6/2021 | NON-COMPETING CONTINUATION | $467,500 |
|
| Issue Date FY: 2020 ( Subtotal = $467,500 ) |
| 2020 | 2020 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111 | PHILADELPHIA | USA | Blood Diseases and Resources Research | 000 | 1 | 1/17/2020 | NEW | $467,500 |
|
|